Surface Acoustic Wave (SAW) Technology: A Non-Invasive Revolution
While the ENvue System handles navigation, the company’s SAW technology platform addresses the aftermath of indwelling device use. UroShield and PainShield are not just accessories; they are disruptive therapeutic tools.
SAW technology creates low-frequency ultrasonic waves that run along the surface of a catheter or a patch on the skin. In the case of UroShield, these waves create an "acoustic shield" that prevents bacteria from adhering to the catheter surface.
This effectively stops the formation of biofilms, which are the primary cause of Catheter-Associated Urinary Tract Infections (CAUTIs). Clinical case series have shown a staggering 94% average reduction in CAUTIs and catheter blockages when using this technology.
Bridging the Gap: From Hospital to Home Care
The recent launch of over-the-counter (OTC) reusable ENFit syringes on January 14th, 2026, marks a strategic pivot toward the home heal-th-care sector. As hospital stays become shorter, the burden of care is shifting to the patient and their family.
These syringes comply with global ISO 80369-3 standards, ensuring they cannot be accidentally connected to the wrong medical lines, a critical safety feature in a home setting.
By offering these without a prescription, ENvue Medical, Inc. is tapping into a recurring revenue model that supports patient continuity of care outside the clinical environment.
Find Report Sources And Important Details Here: FEED Website. -----
5 Potential Catalysts On Radar For ENvue Medical, Inc. (Nasdaq: FEED)
1.) FEED Has A Really Low Float (Volatility Potential Could Be Explosive).
With a float of roughly 860.38k shares, according to Yahoo Finance, the potential for volatility could be present daily.
2.) A 6-Month Chart History Depicts Explosive Behavior Over Short Term Periods.
Take a look at FEED's 6-Month chart. Explosive, right?
On its chart, FEED has displayed the ability to make significant moves in short periods of time.
Now, that's not to say another vertical chart move is going to happen, but take a look at these previous runs for yourself:
- From a 1/27/26 low of $1.02, FEED popped to a high of $6.09 a few days later (497+% run).
- From a 3/15/26 low of $1.05, FEED hit a high of $2.89+ less than 2 weeks later (175+% surge).
- Just this month, FEED has hopped from a May 5th, 2026 low of $1.11 to a high of $1.535 on May 8th, 2026 (38+% move).
#3. ENvue Medical Secures Three-Year Purchasing Agreement Renewal With The Group Purchasing Organization (GPO) For One Of The Largest Heal-th Systems In The U.S. Operating Over 90 Hospitals.
ENvue Medical’s three-year purchasing agreement renewal gives it durable access to a heal-th system spanning more than 90 hospitals across 17 states.
The agreement removes facility-by-facility procurement friction, making adoption faster and easier for participating sites.
That scale matters because it places ENvue’s platform inside a large contracting network with a clear path to broader utilization through 2028.
For ENvue, the deal is a strong commercial signal that can support recurring relationships, expanded installation, and deeper penetration across a major U.S. heal-th system.
#4. ENvue Medical Announces 40th U.S. Hospital Customer With Addition Of A Virginia Medical Center Affiliated With The Mayo Clinic Care Network.
ENvue reached its 40th U.S. hospital customer when a Virginia regional medical center affiliated with the Mayo Clinic Care Network adopted the ENvue Navigation Platform.
The hospital is now shifting feeding tube placement from interventional radiology to a nursing-led bedside model, which highlights the platform’s efficiency and ease of use.
That transition strengthens ENvue’s value proposition by supporting real-time visualization and more standardized care at the point of care.
The win also broadens ENvue’s presence in regional heal-th systems and reinforces growing demand for bedside enteral solutions.
#5. ENvue Medical Adds To Intellectual Property Portfolio By Securing USPTO Notice Of Allowance For Ultrasound-Enhanced Cann-a-binoid Drug Delivery Technology.
ENvue’s USPTO Notice of Allowance for its ultrasound-enhanced cann-a-binoid delivery technology expands the company’s intellectual property footprint into a new therapeutic area.
The allowed claims cover key elements of the SAW-based system, including patch designs, portable platforms, and methods that improve transdermal absorption.
This development is positive because it suggests ENvue’s technology may have applications beyond its current marketed products.
The broader patent protection also strengthens the company’s long-term innovation story and could create additional strategic options as interest in cann-a-binoid therapeutics grows. -----
Coverage is now cooking on ENvue Medical, Inc. (Nasdaq: FEED).
Be on the lookout for updates coming your way shortly. Talk soon.
All the best, Dane James Editor Market Pulse Today
(Remember: St-ock Prices Could Be Significantly Lower Now From The Original Dates I Provided.)
*MarketPulseToday.com (“MarketPulseToday” or “MPT” ) is owned by Thousand Sun Media LLC, MPT is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile MPT brings to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized in-vest-ment advice, are not in-vest-ment advisors, and any profiles we mention are not suitable for all in-vest-ors.
ENvue Medical, Inc. (FEED:US) previously changed their company name and symbols from NanoVibronix Inc. (NAOV:US)
Pursuant to an agreement between Thousand Sun Media LLC and TD Media LLC, Thousand Sun Media LLC has been hired for a period beginning on 05/11/2026 and ending on 05/12/2026 to publicly disseminate information about (FEED:US) via digital communications. Under this agreement, TD Media LLC has paid Thousand Sun Media LLC seven thousand five hundred USD ("Funds"). These Funds were part of the seventy five thousand USD funds that TD Media LLC received from a third party named Goldwyn Media LLC who did receive the Funds directly or indirectly from the Issuer and does not own st-ock in the Issuer but the reader should assume that the clients of the third party own shares in the Issuer, which they will liquidate at or near the time you receive this communication and has the potential to hurt share prices.
Neither Thousand Sun Media LLC, TD Media LLC and their member own shares of (FEED:US).
Please see important disclosure information here: https://marketpulsetoday.com/disclosure/feed-ugdqi/#details |
No comments:
Post a Comment